Kaneka Coenzyme Q10™ This functional foodstuff, which is extracted from yeast by a microbial reaction production method, is drawing interest for use in various food materials, including supplements.

Kaneka Q10

Kaneka Glavonoid™ This performance food product ingredient was developed using Kaneka’s unique technologies. The main component is polyphenol derived from licorice, which is an ingredient used widely in food and other products. With the aim of maintaining health among middle-aged and older people, it can be used in a diverse variety of food products, including supplements, seasonings, drinks and desserts.

AMMPA Kaneka™ (intermediate for anti-hypertensive captopril) Kaneka uses cost-effective microbial reactions and organic synthesis to produce AMMPA.

Kaneka™ AL-1 and AL-2 (intermediates for enalapril-type anti-hypertensives)

Manufactured with organic synthesis technology, these intermediates enable pharmaceutical manufacturers to produce various enalapril-type anti-hypertensives very easily.

Azetidon-Kaneka™ (intermediate for carbapenems and penems)

Kaneka was the first to produce this intermediate for these fourth generation antibiotics by combining microbial reactions and organic synthesis technologies.

API & Pharmaceutical Intermediates

Catheters for treatment inside blood vessels These catheters are used by inserting narrow tubes into blood vessels that have undergone pathological changes in the heart, brain, extremities and other parts of the body in order to treat illnesses inside these vessels. We are developing numerous products for diverse treatment methods, including PTCA balloon catheters.

Kaneka MEDIX

Kaneka QH™ (regenerative coenzyme Q10) We led the world in successfully developing stabilization technologies for regenerative coenzyme Q10 in bulk and soft capsule forms. More than 90% of the coenzyme Q10 in the blood plasma of healthy people is regenerative. This product helps maintain the health of middle-aged and older people whose regenerative abilities have declined.

Kaneka™ Glutathione (glutathione) Kaneka's original fermentation technology produces pharmaceutical bulk for hepatic medicine.

UBIDECARENON KANEKA™ (Coenzyme Q10)

Kaneka was the first to produce ubidecarenone, a pharmaceutical bulk for cardiac medicine, using a completely new microbial fermentation technology.

HPG-Kaneka™ (side chain for semisynthetic penicillins)

In Singapore, Kaneka produces D-p-hydroxyphenyl glycine as a side chain for semi-synthetic -lactam antibiotics such as Amoxicillin.

API & Pharmaceutical Intermediates

KANEKA Plasmapheresis System

(1) SULFLUX

(Membrane-type plasmaseparator)

(2) LIPOSORBER™

(LDL-cholesterol adsorption column)

(3) Selesorb™

(Specific adsorption column for SLE)

(4) Lixelle™

(Adsorption column for dialysis-related amyloidosis)

Kaneka MEDIX

Business Fields

• Chemicals
• Functional Plastics
• Expandable Plastics and
  Products
• Foodstuffs Products
• Life Science Products
• Electronic Products
• Synthetic Fibers